Hemispherx BioPharma, Inc (NYSEAMERICAN:HEB – Get Free Report)’s stock price passed above its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $6.70 and traded as high as $9.00. Hemispherx BioPharma shares last traded at $6.70, with a volume of 7,639 shares trading hands.
Hemispherx BioPharma Trading Down 20.0%
The stock has a fifty day simple moving average of $6.70 and a 200-day simple moving average of $6.70.
About Hemispherx BioPharma
Hemispherx BioPharma, Inc (NYSEAMERICAN:HEB) is a U.S.-based biopharmaceutical company focused on the development and commercialization of immunotherapeutic products for the treatment of viral infections, cancers and immune system disorders. The company’s research centers on harnessing the body’s innate immune response to address diseases that currently lack broadly effective treatments.
Hemispherx’s principal commercial product is Alferon N Injection, an antiviral drug indicated for the treatment of external genital warts.
Featured Articles
- Five stocks we like better than Hemispherx BioPharma
- If You Keep Cash In A U.S. Bank Account… Read This NOW
- Do not delete, read immediately
- How a Family Trust May Be Able To Help Preserve Your Wealth
- GOLD ALERT
- Buy this $2 Gold Stock Before January 1, 2026
Receive News & Ratings for Hemispherx BioPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hemispherx BioPharma and related companies with MarketBeat.com's FREE daily email newsletter.
